Patient-Focused Drug Development: We Shape the Future
It’s been just over a month since our Patient-Focused Drug Development (PFDD) meeting on hyperhidrosis (Hh), but the process is not over. Your – and our -- input will help shape the future of hyperhidrosis care. PFDDs are an important way for us to make our voices and needs heard by treatment developers, healthcare providers, and the U.S. Food and Drug Administration (FDA). Have your say and comment via a “PFDD Comment” email.